首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   25036篇
  免费   1830篇
  国内免费   1418篇
  2023年   302篇
  2022年   379篇
  2021年   1185篇
  2020年   825篇
  2019年   1091篇
  2018年   1052篇
  2017年   832篇
  2016年   1128篇
  2015年   1570篇
  2014年   1766篇
  2013年   2055篇
  2012年   2263篇
  2011年   2095篇
  2010年   1192篇
  2009年   1088篇
  2008年   1190篇
  2007年   1073篇
  2006年   994篇
  2005年   835篇
  2004年   704篇
  2003年   595篇
  2002年   525篇
  2001年   346篇
  2000年   356篇
  1999年   329篇
  1998年   198篇
  1997年   185篇
  1996年   198篇
  1995年   194篇
  1994年   161篇
  1993年   125篇
  1992年   172篇
  1991年   161篇
  1990年   132篇
  1989年   105篇
  1988年   109篇
  1987年   111篇
  1986年   76篇
  1985年   103篇
  1984年   55篇
  1983年   58篇
  1982年   31篇
  1981年   27篇
  1980年   26篇
  1979年   36篇
  1978年   29篇
  1977年   20篇
  1975年   29篇
  1974年   22篇
  1971年   19篇
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
991.
992.
Tang  Jingyao  Xiao  Zhongyin  Xu  Kaikai  Ma  Xiaolong  Wang  Zihua 《Plasmonics (Norwell, Mass.)》2016,11(5):1393-1399
Plasmonics - In this paper, a three-dimensional metamaterial structure absorber has been analyzed and discussed. The unit of the absorber is composed of nine different size resistive films which...  相似文献   
993.
994.
In pharmaceutical sciences, a crucial step of the drug discovery process is the identification of drug-target interactions. However, only a small portion of the drug-target interactions have been experimentally validated, as the experimental validation is laborious and costly. To improve the drug discovery efficiency, there is a great need for the development of accurate computational approaches that can predict potential drug-target interactions to direct the experimental verification. In this paper, we propose a novel drug-target interaction prediction algorithm, namely neighborhood regularized logistic matrix factorization (NRLMF). Specifically, the proposed NRLMF method focuses on modeling the probability that a drug would interact with a target by logistic matrix factorization, where the properties of drugs and targets are represented by drug-specific and target-specific latent vectors, respectively. Moreover, NRLMF assigns higher importance levels to positive observations (i.e., the observed interacting drug-target pairs) than negative observations (i.e., the unknown pairs). Because the positive observations are already experimentally verified, they are usually more trustworthy. Furthermore, the local structure of the drug-target interaction data has also been exploited via neighborhood regularization to achieve better prediction accuracy. We conducted extensive experiments over four benchmark datasets, and NRLMF demonstrated its effectiveness compared with five state-of-the-art approaches.  相似文献   
995.
996.
997.
998.
Patterns of sex‐chromosome differentiation and gonadal development have been shown to vary among populations of Rana temporaria along a latitudinal transect in Sweden. Frogs from the northern‐boreal population of Ammarnäs displayed well‐differentiated X and Y haplotypes, early gonadal differentiation, and a perfect match between phenotypic and genotypic sex. In contrast, no differentiated Y haplotypes could be detected in the southern population of Tvedöra, where juveniles furthermore showed delayed gonadal differentiation. Here, we show that Dmrt1, a gene that plays a key role in sex determination and sexual development across all metazoans, displays significant sex differentiation in Tvedöra, with a Y‐specific haplotype distinct from Ammarnäs. The differential segment is not only much shorter in Tvedöra than in Ammarnäs, it is also less differentiated and associates with both delayed gonadal differentiation and imperfect match between phenotypic and genotypic sex. Whereas Tvedöra juveniles with a local Y haplotype tend to ultimately develop as males, those without it may nevertheless become functional XX males, but with strongly female‐biased progeny. Our findings suggest that the variance in patterns of sex determination documented in common frogs might result from a genetic polymorphism within a small genomic region that contains Dmrt1. They also substantiate the view that recurrent convergences of sex determination toward a limited set of chromosome pairs may result from the co‐option of small genomic regions that harbor key genes from the sex‐determination pathway.  相似文献   
999.
Grazing and fencing are two important factors that influence productivity and biomass allocation in alpine grasslands. The relationship between root (R) and shoot (S) biomass and the root:shoot ratio (R/S) are critical parameters for estimating the terrestrial carbon stocks and biomass allocation mechanism responses to human activities. Previous studies have often used the belowground:aboveground biomass ratio (Mb/Ma) to replace the R/S in alpine ecosystems. However, these studies may have neglected the leaf meristem biomass, which belongs to the shoot but occurs below the soil surface, leading to a significant overestimation of the R/S ratio. We conducted a comparative study to explore the differences between the R/S and Mb/Ma at both the species (Stipa purpurea, Carex moorcroftii, and Artemisia nanschanica) and community levels on a Tibetan alpine grassland with grazing and fencing management blocks. The results revealed that the use of the Mb/Ma to express the R/S appeared to overestimate the actual value of the R/S, both at species and community levels. For S. purpurea, the Mb/Ma was three times higher than the R/S. The Mb/Ma was approximately two times higher than the R/S for the species of C. moorcroftii and A. nanschanica and at the community level. The relationships between the R‐S and MbMa exhibited different slopes for the alpine plants across all the management practices. Compared to the fenced grasslands, the plants in the grazing blocks not only allocated more biomass to the roots but also to the leaf meristems. The present study highlights the contribution of leaf meristems to the accurate assessment of shoot and belowground biomasses. The R/S and Mb/Ma should be cautiously used in combination in the future research. The understanding of the distinction between the R‐S and MbMa may help to improve the biomass allocation mechanism response to human disturbances in an alpine area.  相似文献   
1000.

Background and Purpose

Short-term combined use of clopidogrel and aspirin improves cerebrovascular outcomes in patients with symptomatic extracranial or intracranial stenosis. Antiplatelet non-responsiveness is related to recurrent ischemic events, but the culprit genetic variants responsible for the non-responsiveness have not been well studied. We aimed to identify the genetic variants associated with poor clinical outcomes.

Methods

Patients with symptomatic extracranial or intracranial stenosis scheduled for stenting and receiving dual antiplatelets (clopidogrel 75 mg and aspirin 100 mg daily) for at least 5 days before intervention were enrolled. Ischemic events including recurrent transient ischemic attack, stroke, myocardial infarction, and vascular-related mortality within 12 months follow-up were recorded. We examined the influence of genetic polymorphisms on treatment outcome in our patients.

Results

A total of 268 patients were enrolled into our study and ischemic events were observed in 39 patients. For rs662 of paraoxonase 1 (PON1), allele C was associated with an increased risk of ischemic events (OR = 1.64, 95%CI = 1.03–2.62, P = 0.029). The A-allele carriers of rs2046934 of P2Y12 had a significant association with adverse events (OR = 2.01, 95%CI = 1.10–3.67, P = 0.041). The variant T-allele of cyclooxygenase-1 (COX1) rs1330344 significantly increased the risk of recurrent clinical events (OR = 1.85, 95%CI = 1.12–3.03, P = 0.017). The other single nucleotide polymorphism (SNP) had no association with ischemic events.

Conclusions

PON1, P2Y12 and COX1 polymorphisms were associated with poorer vascular outcomes. Testing for these polymorphisms may be valuable in the identification of patients at risk for recurrent ischemic events.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号